FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetesFDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 29, 2023 at 2:27 PM in business No comments 35
Pfizer, Opko gain FDA nod for weekly growth hormone drug Ngenla - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 28, 2023 at 2:42 PM in business No comments 27
Regeneron's high-dose Eylea hit with surprise FDA rejection over manufacturing hiccupsRegeneron's high-dose Eylea hit with surprise FDA rejection over manufacturing hiccups - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 27, 2023 at 9:14 PM in business No comments 6
FDA signs off on UCB's myasthenia gravis drug Rystiggo - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 27, 2023 at 3:28 PM in business No comments 17
NICE puts kibosh on Mounjaro coverage over GLP-1 comparison and cost model uncertainties - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 27, 2023 at 3:16 PM in health No comments 48
In approving Sarepta's DMD gene therapy, FDA's Peter Marks overruled reviewers' rejection - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 26, 2023 at 3:35 PM in business No comments 45
After metastatic disease win, Merck's Keytruda flunks trial in early stomach cancerAfter metastatic disease win, Merck's Keytruda flunks trial in early stomach cancer - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on June 22, 2023 at 1:50 PM in business No comments 60